LMRA

[ramlau]

Ramlau, did get sell or buy more LMRA ?

Bought more today. Don't see much downside risk.

Ram

[422fwhp]

I bought some today as well...agree, not much downside risk.

GLTA...Jody

[REALDEALS21]

Looks like LMRA wants to run a little today !

[alvin58]

Looks like LMRA wants to run a little today !

I thought that to. This stock is really hard to follow. About the time you think its safe to buy it tanks again. Very fast mover. I think Ill wait to see if it settles for a few days.

[422fwhp]

I added on the half day friday...it's up PM

3 magic lines?

[422fwhp]

News out pm...up +10%...too bad I got stopped out a day ago!   

[David Randolph]

News out pm...up +10%...too bad I got stopped out a day ago!   

Here's the news out: Lumera Achieves Multi-Band Millimeter Wave Communications System Milestone with Successful Test of Wireless Bridge at 10Gbps

Up 15% on pre-market as we write (although the news doesn't seem to be that significant, short covering, perhaps?). Market cap of about $125 M ... what's the story on this one? It's certainly a big mover.

[David Randolph]

The news that made it run so much on October 16 was similar, take a look:

Lumera shares jump on successful test of MMW system
at MarketWatch (Mon, Oct 16)

Fundamentally it is impossible to justify the current valuation, only by the market size and potential of these apparently new technologies. What's their market size, anybody has a clue? I don't ...

Anyway, the good news seems priced in to me, we're talking about a $125 M market cap with $1 M in sales over Q3 and $2.7 M in losses ... and the share count is probably rising, as it almost always happens after a short term surge in a small cap like this (well, not so small).

[wontfindaname]

This one should have a good January. They are unveiling their Proteomic Processor (biotech drug discovery equipment) on Jan 12th. Each of these sells at half a million bucks with more for supplies. Their main competition in this sector, Biacore, was bought for $438 million by GE Healthcare. In addition to this technology, they have other promising technology in communication (MMW) and satellites.

[setravis]

"LMRA" Threads have been Merged.
Please use the search before starting new threads on a Stock Pick.
Chances are a thread already exist.
So why not post whatever you have to comment about on that pick to that thread.
"Simplicity" My fellow traders.                   
All history on a stock pick in 1 thread is awesome.                 
Just trying to get threads together,so we don't have a numerous amount floating around on the same stock.
Thank You....and good luck with all your trades....make some $$$        
   

Happy New Year ! May it be Prosperous for all @ 3SOF......   

[wontfindaname]

I found the December short interest data at http://www.nasdaqtrader.com/asp/short_interest_resp.asp?symbol=lmra&SettlementDate=12%2F15%2F2006&View.x=0&View.y=0

         Short Interest    Percent Change    Average Daily Share Volume    Days to
Cover
LMRA    Lumera Corporation - Common Stock   3,474,509   9.97   2,060,994   1.69

That is over 1/3 of the traded float. The next positive news event is going to be brutal for the shorts. The only danger is that the shorts might try to short more to protect their position. I think that is what happened with the latest news of the positive multiband test data.

I anticipate 2 important news events this month:

1. Independent third party confirmation of MMW transmission test (which is currently delayed from November)
2. Unveiling of the Proteomic Processor on Jan 12th.

I hope there is some kind of strategic partnership/buyout of one of their divisions, which is going to be insane. A good strategy would be to go long now and sell on top of the short fueled explosion and possibly short some on top before the inevitable return to sanity. I don't think I will short though (as I think my personality is unsuited to assuming that kind of risk).

[setravis]

"MVIS" is a Major Holder of LMRA, 1,750,000 holding as of 10-17-06
Buying the dip.
Buy more at $5.35 if it gets that low. Watch out for wide swings - very volatile sometimes.
Lumera Corporation engages in the development, manufacture, and marketing of devices using proprietary polymer materials primarily in the United States. It offers proprietary polymer materials and products based on these materials for bioscience and electro-optics markets.

[setravis]

Looks great, good volume...

[wontfindaname]

Ugh. This stock has been really disappointing over the last few months! Any ideas on what the bottom is on this one? Thanks.

[la-onda]

fyi:
Knobias clipreport:
One company deeply ingrained in the research of nanotechnology is Lumera Corporation (LMRA). The Company is concentrated primarily on the development of their proprietary polymer materials and products based on these materials for two primary markets: bioscience and electro-optics. They use their expertise in nanotechnology to design and synthesize these polymer materials at the molecular level. These materials are used in two very specific ways that will enable the Company to enter two vastly different markets but both with huge growth opportunities.
Knobias spoke with investor relations spokesperson for Lumera Corporation, Hélène F. Jaillet, about the Company and some of its opportunities.
"We were founded in October of 2000 and began to work on patents that we licensed from the University of Washington. At the time, the application was aimed towards the telecommunications industry which was experiencing tremendous growth," noted Jaillet. "After the telecommunication sector saw its falling out, our scientists saw that this technology could be employed in the bioscience sector."
The Company is currently developing their ProteomicProcessor(TM) in this sector. This compact device is used for detecting and quantifying binding interactions in a label-free format utilizing Surface Plasmon Resonance
(SPR) technology. The application is in the proteomics arena and used to facilitate drug makers in identifying possible compounds. This arena is specifically called the compound screening market. "The total market for compound screening in 2005 was around $2.3B, which includes instruments and consumable biochips. This market is somewhat like the razor blade market where the real revenue growth comes from selling the razor blades," said Jaillet. One of Lumera's competitors in this market was Biacore.
"They were acquired by GE Healthcare for over $350M last summer," noted Jaillet, "Our photonics approach uses a MEMS scanner which is scalable and allows higher throughput where their approach uses a fixed beam of light."
The Company also has an electro-optics division which focuses on modulators used in fiber optic transmissions that features the fastest switching speeds with the lowest drive voltages and optical losses in the industry.
In October, the Company announced that it had completed successful testing of its millimeter wave wireless bridge that will enable government and commercial entities to transmit vast amounts of data via a variety of high speed telecommunications networks. The test included transmitting 10 Gbps at 94 GHz, through the use of Gigabit Ethernet and other standard protocols.
In December, the Company announced testing of its multi-frequency band prototype, which is designed to transmit data at spectrum frequencies of 35, 94, and 140 GHz. Data rates from 2.5 Gbps to 10 Gbps were successfully tested and Lumera anticipated that the system will have the capacity to operate at a range of up to three miles per data link. In addition to high data rate transmission, the multi-band system offers adaptive frequency switching to provide link resilience by responding to changes in atmospheric conditions.
The amount of data is unmatched in the industry and is the equivalent of downloading six DVDs in one minute. "The speed of transmission is ten times faster than anything else in the industry," noted Jaillet. "We are unrivaled
at the speed of our system."
Fundamentally, the Company's balance sheet is in superb shape. They have no debt and have ample cash in the bank. With everything in place, the only risk now is execution of their marketing plan. Though their fourth quarter earnings (expected to be released on or around March 5th) might not display the ground breaking numbers, the name is certainly one to watch over the coming quarters.

http://www.knobias.com/clipreport/clipreport.pdf